Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K‐ras status for unresectable colorectal liver metastasis (BECK study)

Publisher: John Wiley & Sons Inc

E-ISSN: 1868-6982|22|8|634-645

ISSN: 1868-6974

Source: JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol.22, Iss.8, 2015-08, pp. : 634-645

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract